Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
On-Q-ity logo — Empowering physicians with advanced tools to improve cancer...

On-Q-ity

Empowering physicians with advanced tools to improve cancer treatment decisions and enhance patient outcomes.

Founded 2004 Series B Total: $31.00M Biotechnology, Health Care

General Information

Company Name On-Q-ity
Founded Year 2004
Industries Biotechnology, Health Care
Funding Stage Series B
Social

BounceWatch is an independent company data service, not affiliated with On-Q-ity. To contact On-Q-ity, visit on-q-ity.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does On-Q-ity compare?

A PDF of On-Q-ity and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting On-Q-ity soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About On-Q-ity

On-Q-ity is a biotechnology startup founded in 2004 and is dedicated to providing physicians with advanced tools to improve cancer treatment decisions and enhance patient outcomes. The company's slogan "Empowering physicians with advanced tools to improve cancer treatment decisions and enhance patient outcomes" reflects its mission to optimize cancer treatment decisions for individual patients. On-Q-ity's platform leverages DNA repair biomarkers for predicting treatment response and microfluidic chip technology for capturing, enumerating, and characterizing circulating tumor cells (CTCs) in the bloodstream. The last investment in On-Q-ity was a $5.00M Series B round led by Atlas Venture, Mohr Davidow Ventures, and Physic Ventures on 28 February 2012. This investment signifies the confidence of established venture capital firms in On-Q-ity's potential to make a significant impact in the biotechnology industry. With a focus on improving decision-making across various cancers and ultimately improving patient quality of life and survival rates, On-Q-ity is likely to attract further attention and investment in the future.

Business keywords: Diagnostic company, Cancer treatment, Physician tools, DNA repair biomarkers, Microfluidic chip technology, Treatment decision support, Precision medicine, Circulating tumor cells (CTCs), Personalized medicine

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series B On Q $5.00M 3
Atlas Venture Mohr Davidow Ventures Physic Ventures
Atlas Venture, Mohr Davidow Ventures +1
28 Feb 2012
Series A On Q $26.00M 5
Bessemer Venture Partners Atlas Venture Mohr Davidow Ventures
Bessemer Venture Partners, Atlas Venture +3
14 Dec 2009

On-Q-ity Alternatives & Competitors

View All Alternatives
On-Q-ity vs
IV Diagnostics
IV Diagnostics

Advancing Early Cancer Detection with Circulating Tumor Cells for Improved Prognosis and Disease Man...

Private Equity
Biotechnology, Health Care
On-Q-ity vs
Vortex Biosciences
Vortex Biosciences United States

Circulating Tumor Cells (CTCs) are cancer cells, which have detached from the primary tumor and have...

Venture round
7 employees
Biotechnology, Health Care
On-Q-ity vs
GILUPI GmbH
GILUPI GmbH Germany

Advancing diagnostic procedures for precision medicine

Acquired
8 employees
Biotechnology, Health Care
Also compare with: On-Q-ity vs CellMax Life CellMax Life View all alternatives

FAQ About On-Q-ity

Empowering physicians with advanced tools to improve cancer treatment decisions and enhance patient outcomes.
On-Q-ity was founded in 2004.
On-Q-ity operates in Biotechnology and Health Care. Its work centres on Diagnostic company, Cancer treatment, Physician tools and DNA repair biomarkers.
On-Q-ity has completed 2 funding rounds, raising a total of $31.00M. The latest funding stage is Series B.
Top alternatives and competitors to On-Q-ity include IV Diagnostics, Vortex Biosciences, GILUPI GmbH, Cellsway, CellMax Life. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
On-Q-ity and IV Diagnostics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for On-Q-ity, https://bouncewatch.com/company/on-q-ity, updated 10 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes